Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (18)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by McNally, N.
Right arrow Articles by Farrar, G. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by McNally, N.
Right arrow Articles by Farrar, G. J.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Molecular Genetics, 1999, Vol. 8, No. 7 1309-1312
© 1999 Oxford University Press

Structural and functional rescue of murine rod photoreceptors by human rhodopsin transgene

Niamh McNally, Paul Kenna, Marian M. Humphries, Audrey H. Hobson, Noheed W. Khan1, Ron A Bush1, Paul A. Sieving1, Peter Humphries and G. Jane Farrara

The Ocular Genetics Unit, Institute of Genetics, Trinity College, Dublin 2, Ireland and 1W.K. Kellogg Eye Centre, University of Michigan, Ann Arbor, MI 48105, USA

Mice carrying a targeted disruption of the rhodopsin gene develop a severe degenerative retinopathy, failing to elaborate rod photoreceptor outer segments (ROS), having no recordable rod electroretinogram (ERG) and losing all of their rod cells over a period of ~12 weeks. Murine and human rhodopsins differ in their amino acid sequences. Whether, or to what extent, such variability might influence the ability of human rhodopsin to serve as an adequate structural and functional substitute for the endogenous protein in mouse rod cells bears direct relevance to exploiting the full utility of Rho–/– animals as a model of degenerative retinal disease in man. We crossed Rho–/– mice with mice expressing a wild-type human rhodopsin transgene at levels approximating to those of the endogenous protein. Immunohistological examination of retinal selections from such animals demonstrated ROS of normal number and length and temporal expression of rhodopsin similar to that observed in wild-type animals; that is, immunoreactivity to an anti-rhodopsin antibody became clearly evident by day 3 post-partum. Whereas Rho–/– mice never display a rod ERG response, and even lose cone responses by 12 weeks of age, rescued mice showed 75% normal maximum amplitudes and had ERG b-wave thresholds (based on a 50 µV criterion) within 0.1 log unit of normal wild-type at 20 weeks, and cone amplitudes remained normal at this age. These data demonstrate very substantial structural and functional rescue of the rod photoreceptors of Rho–/– mice and long-term preservation by the human rhodopsin transgene.

a To whom correspondence should be addressed. Tel: +353 1 6082484; Fax: +353 1 6719394; Email: gjfarrar{at}vax1.tcd.ie


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
D. Deretic, A. H. Williams, N. Ransom, V. Morel, P. A. Hargrave, and A. Arendt
Rhodopsin C terminus, the site of mutations causing retinal disease, regulates trafficking by binding to ADP-ribosylation factor 4 (ARF4)
PNAS, March 1, 2005; 102(9): 3301 - 3306.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
S. T. Menon, M. Han, and T. P. Sakmar
Rhodopsin: Structural Basis of Molecular Physiology
Physiol Rev, October 1, 2001; 81(4): 1659 - 1688.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
P. A. Sieving, M. L. Fowler, R. A. Bush, S. Machida, P. D. Calvert, D. G. Green, C. L. Makino, and C. L. McHenry
Constitutive "Light" Adaptation in Rods from G90D Rhodopsin: A Mechanism for Human Congenital Nightblindness without Rod Cell Loss
J. Neurosci., August 1, 2001; 21(15): 5449 - 5460.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Durbeej and K. P. Campbell
Biochemical Characterization of the Epithelial Dystroglycan Complex
J. Biol. Chem., September 10, 1999; 274(37): 26609 - 26616.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. Imamura and E. Ozawa
Differential expression of dystrophin isoforms and utrophin during dibutyryl-cAMP-induced morphological differentiation of rat brain astrocytes
PNAS, May 26, 1998; 95(11): 6139 - 6144.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.